Back to results
US 2021/0275679 A1Published application
Heparosan polymers and methods of making and using same for the enhancement of therpeutics
AssigneeThe Board of Regents of the University of Oklahoma
InventorPaul L. DEANGELIS
Life of this patent
Estimating the term…
Abstract
Compositions, methods, and systems for the development and use of heparosan as a therapeutic modifying agent or vehicle which can modulate drug cargo pharmacokinetics and behavior within a mammalian patient.
Claims18
A non-immunogenic pharmaceutical drug delivery composition for treating a disease condition in a mammalian patient, the pharmaceutical composition comprising:
- one or more heparosan-drug conjugates, wherein each conjugate comprises:
- at least one heparosan polymer, wherein the at least one heparosan polymer is unsulfated;
- and
- at least one therapeutic non-peptide drug conjugated to the at least one heparosan polymer, wherein the at least one therapeutic non-peptide drug treats a mammalian disease condition and remains active when conjugated to the at least one heparosan polymer;
- and
- a pharmaceutically acceptable carrier;
- and
- wherein the pharmaceutical drug delivery composition is a sterile pharmaceutical formulation in a unit dosage format.
5 more elements
Dependencies are inferred from the claim text.